Cargando…
Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology
With a global prevalence of ~9%–12%, low back pain (LBP) is a serious public health issue, associated with high costs for treatment and lost productivity. Chronic LBP (cLBP) involves central sensitization, a neuropathic pain component, and may induce maladaptive coping strategies and depression. Tre...
Autores principales: | Pergolizzi, Joseph V, Raffa, Robert B, Fleischer, Charles, Zampogna, Gianpietro, Taylor, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096757/ https://www.ncbi.nlm.nih.gov/pubmed/27826213 http://dx.doi.org/10.2147/JPR.S87952 |
Ejemplares similares
-
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2016) -
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017) -
Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain
por: Pergolizzi Jr, Joseph V, et al.
Publicado: (2019) -
Formulation and Characterization of Mucoadhesive Buccal Films of Glipizide
por: Semalty, Mona, et al.
Publicado: (2008) -
Mucoadhesive buccal films of glibenclamide: Development and evaluation
por: Muzib, Y Indira, et al.
Publicado: (2011)